AgeneBio Appoints Industry Leaders Patrick LePore as Chairman of the Board and Jerry McLaughlin as President and Chief Executive Officer

BALTIMORE, MARYLAND—AgeneBio, Inc., a clinical-stage pharmaceutical company developing medicines to restore and preserve patients’ cognitive function for a range of debilitating neurodegenerative diseases, today announced the appointment of Patrick LePore as chairman of the board and Jerry McLaughlin as president and chief executive officer. Both appointments are effective immediately. “Pat and Jerry are distinguished leaders…